🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "focused action to address household expense pressures" in the upcoming financial statement.

Speaking to media outlets, she emphasized that reducing price rises is a collective responsibility of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Energy Bill Interventions

It is understood the administration could take action to bring down energy bills, such as by cutting the present 5% rate of value-added tax applied on energy supplies.

A further possibility is to reduce some of the policy costs presently added to bills.

Fiscal Constraints and Analyst Predictions

The government will receive the latest report from the official forecaster, the OBR, on the start of the week, which will show how much room there is for these measures.

The expectation from the majority of economists is that the Chancellor will have to announce tax increases or budget cuts in order to meet her self-imposed borrowing rules.

Earlier on the same day, analysis indicated there was a £22bn shortfall for the chancellor to fill, which is at the more modest range of expectations.

"It is a joint task between the central bank and the administration to continue tackling some of the causes of price increases," the Chancellor told the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While much of the focus has been on probable tax increases, the Treasury chief said the most recent figures from the OBR had not changed her pledge to campaign commitments not to raise tax levels on income tax, VAT or National Insurance.

She blamed an "uncertain global environment" with increasing geopolitical and commercial tensions for the fiscal tax moves, likely to be targeted on those "most able to pay."

Global Trade Tensions

Addressing apprehensions about the United Kingdom's economic relations with China she said: "The UK's national security always are paramount."

Recent announcement by China to strengthen trade restrictions on critical minerals and other resources that are essential for advanced tech manufacturing led American leader the US President to threaten an extra 100% import tax on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary described the Chinese decision "economic coercion" and "a international production control attempt."

Inquired about considering the US offer to participate in its dispute with the Asian nation, Reeves said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "harmful for the world economy and creates additional obstacles."

"In my view there are fields where we need to challenge Chinese policies, but there are also significant opportunities to export to Chinese markets, including banking sector and other areas of the economic system. We've got to get that equilibrium correct."

The Treasury chief also affirmed she was cooperating with other major economies "regarding our own essential resources approach, so that we are reduced dependence."

NHS Drug Costs and Funding

Reeves also admitted that the cost the NHS pays for drugs could go up as a result of current negotiations with the US government and its pharmaceutical firms, in exchange for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or abandoning projects in the United Kingdom, with several attributing the insufficient payments they are receiving.

Recently, the government science advisor said the price the NHS pays for medicines would need to go up to halt companies and pharmaceutical investment leaving the United Kingdom.

Reeves informed the BBC: "It has been observed due to the cost structure, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other EU nations."

"Our aim is to make sure that people receiving treatment from the National Health Service are able to access the best critical medicines in the world. And so we are examining this situation, and... seeking to secure additional funding into the UK."